October 26, 2015 / 4:07 PM / 2 years ago

BUZZ-VBI Vaccines Inc: To be acquired by SciVac Therapeutics

1 Min Read

** Vaccine developer VBI's shares up 11.5 pct at $2.66

** 421,266 shares changed hands by 11:55 a.m. ET, more than 115 times their 25-day average

** SciVac Therapeutics Inc to buy VBI with VBI shareholders receiving shares, options, warrants of SciVac representing 46 pct of combined company

** Combined company to have licensed hepatitis B vaccine and a pipeline of vaccine candidates

** Up to Friday's close, stock had fallen 30 pct this year

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below